GNRH-AGONIST CO-TREATMENT DURING CHEMOTHERAPY FOR THE PRESERVATION OF OVARIAN FUNCTION: A META-ANALYSIS.

被引：1
|
作者：
Gharwan, H. [1 ]
Wilkerson, J. [1 ]
Fojo, A. T. [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
FERTILITY AND STERILITY | 2014年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2014.07.544
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-59
引用
收藏
页码：E159 / E159
页数：1
相关论文
共 50 条
  • [1] GONADOTROPIN-RELEASING HORMONE ANALOG CO-TREATMENT FOR PRESERVATION OF OVARIAN FUNCTION DURING GONADOTOXIC CHEMOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Bedaiwy, M. A.
    Abou-Setta, A. M.
    Desai, N.
    Hurd, W.
    El-Nashar, S. A.
    Falcone, T.
    FERTILITY AND STERILITY, 2010, 94 (04) : S106 - S106
  • [2] Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
    Clowse, Megan E. B.
    Behera, Millie A.
    Anders, Carey K.
    Copland, Susannah
    Coffman, Cynthia J.
    Leppert, Phyllis C.
    Bastian, Lori A.
    JOURNAL OF WOMENS HEALTH, 2009, 18 (03) : 311 - 319
  • [3] Ovarian Function Preservation by GnRH Agonists during Chemotherapy
    Blumenfeld, Zeev
    JOURNAL OF WOMENS HEALTH, 2009, 18 (09) : 1471 - 1471
  • [4] Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: A meta-analysis.
    Baruffi, R. L.
    Mauri, A. L.
    Petersen, C. G.
    Cavagna, M.
    Oliveira, J. B.
    Franco, J. G., Jr.
    FERTILITY AND STERILITY, 2006, 86 : S413 - S413
  • [5] Protection of ovarian function by GnRH agonists during chemotherapy: A meta- analysis
    Sun, Xiaomei
    Dongol, Samina
    Jiang, Jie
    Kong, Beihua
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (04) : 1335 - 1340
  • [6] Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer
    Huang, Yaping
    Huang, Xiaoting
    Huang, Xiaojia
    Lin, Shen
    Luo, Shaohong
    Gu, Dian
    Weng, Xiuhua
    Xu, Xiongwei
    HUMAN REPRODUCTION, 2023, 38 (06) : 1099 - 1110
  • [7] Preservation of ovarian follicle by concomitant administration of GnRH agonist or GnRH antagonist during cyclophosphamide or paclitaxel chemotherapy in mice
    Yang, H. S.
    Kim, M. W.
    HUMAN REPRODUCTION, 2017, 32 : 364 - 364
  • [8] SYSTEMATIC REVIEW AND META-ANALYSIS OF GnRH AGONIST FOR PRESERVATION OF OVARIAN FUNCTION IN WOMEN WITH HORMONE RECEPTOR NEGATIVE BREAST CANCER AFTER CHEMOTHERAPY.
    Vitek, W.
    Hoeger, K.
    Han, Y.
    Messing, S.
    Shayne, M.
    Fung, C.
    FERTILITY AND STERILITY, 2013, 100 (03) : S117 - S117
  • [9] Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy
    Ismail-Khan, R.
    Minton, S.
    Cox, C.
    Sims, I.
    Lacevic, M.
    Gross-King, M.
    Xu, P.
    Carter, B.
    Munster, P. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Comment on GnRH analogue cotreatment with chemotherapy for preservation of ovarian function
    Balkenende, Eva
    Dahhan, Taghride
    van der Veen, Fulco
    Goddijn, Mariette
    FERTILITY AND STERILITY, 2011, 96 (04) : E155 - E156
12345